Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Eisai Inc drug HALAVEN appeared first on DrugPa…
New patent expiration for Eisai Inc drug HALAVEN Read Post »
Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Antares Pharma drug XYOSTED …
New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) Read Post »
Annual Drug Patent Expirations for TAZVERIK Tazverik is a drug marketed by Epizyme Inc and is included in one NDA. It is available from one supplier. There are twenty-four patents…
The post New patent for Epizyme Inc drug TAZVERIK appeared first on Dru…
Annual Drug Patent Expirations for RAVICTI Ravicti is a drug marketed by Horizon Therap Us and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent for Horizon Therap drug RAVICTI appeared first on DrugPaten…
Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…
Pharmaceutical companies with the most orphan drugs Read Post »
Annual Drug Patent Expirations for BENDEKA Bendeka is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are sixteen patents…
The post New patent for Eagle Pharms drug BENDEKA appeared first on DrugPate…
Annual Drug Patent Expirations for TARPEYO Tarpeyo is a drug marketed by Calliditas and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Calliditas drug TARPEYO appeared first on DrugPat…
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier. There are ten patents protecting…
The post New patent for Springworks drug OGSIVEO appeared first on Dru…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Germany. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Germany? Read Post »
Annual Drug Patent Expirations for PYLARIFY Pylarify is a drug marketed by Progenics Pharms Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Progenics Pharms drug PYLARIFY appeared first on Drug…
Get new actionable insights and updates from BiotechBlog
